|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
26
|
|
pubmed:dateCreated |
2006-9-11
|
|
pubmed:abstractText |
We developed a multigene predictor of pathologic complete response (pCR) to preoperative weekly paclitaxel and fluorouracil-doxorubicin-cyclophosphamide (T/FAC) chemotherapy and assessed its predictive accuracy on independent cases.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AndersonKeithK,
pubmed-author:BooserDanielD,
pubmed-author:BuzdarAman UAU,
pubmed-author:DempseyPeter JPJ,
pubmed-author:GómezHenry LHL,
pubmed-author:HessKenneth RKR,
pubmed-author:HortobagyiGabriel NGN,
pubmed-author:IbrahimNuhadN,
pubmed-author:MejiaJaime AJA,
pubmed-author:PusztaiLajosL,
pubmed-author:RossJeffrey SJS,
pubmed-author:RouzierRomanR,
pubmed-author:SneigeNourN,
pubmed-author:SymmansW FraserWF,
pubmed-author:TheriaultRichard LRL,
pubmed-author:ValeroVicenteV,
pubmed-author:VidaurreTatianaT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4236-44
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16896004-Adult,
pubmed-meshheading:16896004-Aged,
pubmed-meshheading:16896004-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16896004-Breast Neoplasms,
pubmed-meshheading:16896004-Cyclophosphamide,
pubmed-meshheading:16896004-Doxorubicin,
pubmed-meshheading:16896004-Female,
pubmed-meshheading:16896004-Fluorouracil,
pubmed-meshheading:16896004-Gene Expression Profiling,
pubmed-meshheading:16896004-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16896004-Humans,
pubmed-meshheading:16896004-Microarray Analysis,
pubmed-meshheading:16896004-Middle Aged,
pubmed-meshheading:16896004-Neoplasm Staging,
pubmed-meshheading:16896004-Oligonucleotides,
pubmed-meshheading:16896004-Paclitaxel,
pubmed-meshheading:16896004-Predictive Value of Tests,
pubmed-meshheading:16896004-ROC Curve,
pubmed-meshheading:16896004-Reproducibility of Results,
pubmed-meshheading:16896004-Sensitivity and Specificity
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
|
|
pubmed:affiliation |
Department of Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
